+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) Treatment Market in APAC 2024-2028

  • Report
  • October 2024
  • 126 Pages
  • Asia Pacific
From
Peanut Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
North America Sodium-Dependent Glucose Co-Transporter 2 (SGLT2) Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028) - Product Thumbnail Image

North America Sodium-Dependent Glucose Co-Transporter 2 (SGLT2) Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

  • Report
  • August 2023
  • 75 Pages
  • North America
From
Antiemetic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 179 Pages
  • Global
From
Gastrointestinal Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gastrointestinal Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 193 Pages
  • Global
From
Thematic Intelligence - The Impact of Inflation on the Healthcare Sector - H2 2023 - Product Thumbnail Image

Thematic Intelligence - The Impact of Inflation on the Healthcare Sector - H2 2023

  • Report
  • December 2023
  • 79 Pages
  • Global
From
Friedreich Ataxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Friedreich Ataxia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 102 Pages
  • Global
From
Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Contrast Agents Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • August 2024
  • 483 Pages
  • Global
From
CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025 - Product Thumbnail Image

CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2025

  • Report
  • April 2025
  • 220 Pages
  • Global
From
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 68 Pages
  • Global
From
Fragile X Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Fragile X Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 126 Pages
  • Global
From
Human Embryonic Stem Cells - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Human Embryonic Stem Cells - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 110 Pages
  • Global
From
Fibromyalgia Treatment - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Treatment - Global Strategic Business Report

  • Report
  • June 2025
  • 276 Pages
  • Global
From
Bipolar Disorder Therapeutics Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market Report 2025

  • Report
  • January 2025
  • 200 Pages
  • Global
From
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 1834 Pages
  • Global
From
Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies - Product Thumbnail Image

TCR Therapy Market Industry Trends and Global Forecasts to 2035, by Target Indication, Target Antigen, Key Players and Key Geographies

  • Report
  • January 2025
  • 363 Pages
  • Global
From
Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions - Product Thumbnail Image

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

  • Report
  • November 2024
  • 716 Pages
  • Global
From
Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 269 Pages
  • Global
From
Loading Indicator